Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial

Diabetic Medicine

Volumn 23, Issue 2, 2006, Pages 141-147

  Hoogma, R P L M ^a   Hammond, P J ^b   Gomis, R ^c   Kerr, D ^d   Bruttomesso, D ^e   Bouter, K P ^f   Wiefels, K J ^g   De La Calle, H ^h   Schweitzer, D H ⁱ   Pfohl, M ^j   Torlone, E ^k   Krinelke, L G ^l   Bolli, G B ^k  

^a GROENE HART HOSPITAL   (Netherlands)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^c HOSPITAL CLÍNIC   (Spain)

^d Bournemouth Diabetes and Endocrine Centre   (United Kingdom)

^e UNIVERSITY OF PADOVA   (Italy)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ REINIER DE GRAAF HOSPITAL   (Netherlands)

^j Evangelisches BETHESDA Krankenhaus zu Duisburg GmbH   (Germany)

^k UNIVERSITY OF PERUGIA   (Italy)

^l Disetronic Medical Systems AG   (Switzerland)

more..

Author keywords

Continuous subcutaneous insulin infusion; Hypoglycaemia; Multiple daily injections; Quality of life; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; AGED; APPLICATION SITE REACTION; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; CROSSOVER PROCEDURE; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PERCEPTIONS QUESTIONNAIRE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INJECTION SITE CELLULITIS; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; INJECTION SITE REACTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INTERMETHOD COMPARISON; LIPOHYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL HEALTH; METABOLIC DISORDER; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCORING SYSTEM; SELF REPORT; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33645051721     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01738.x     Document Type: Article

References (30)

1. Diabetes Control and Complications Trial Research Group (DCCT). Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial Ophthalmology 1995 102 647 661
2. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993 329 977 986
3. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial Diabetes Care 1995 18 361 376
4. Knight G Risks with continuous subcutaneous insulin infusion can be serious Br Med J 1999 319 104 106
5. Lenhard MJ Reeves GD Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy Arch Intern Med 2001 161 2293 2300
6. Pickup J Mattock M Kerry S Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials Br Med J 2002 324 1 6
7. Hanaire-Broutin H Melki V Bessieres-Lacombe S Tauber JP Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes Diabetes Care 2000 23 1232 1235
8. Weissberg-Benchell J Antisdel-Lomaglio J Seshadri R Insulin pump therapy: a meta-analysis Diabetes Care 2003 26 1079 1087
9. Bolli GB Di Marchi RD Park GD Pramming S Koivisto VA Insulin analogues and their potential in the management of diabetes mellitus Diabetologia 1999 42 1151 1167
10. Lalli C Ciofetta M Del Sindaco P Torlone E Pampanelli S Compagnucci P et al. Long-term intensive treatment of Type 1 diabetes with the short-acting insulin analogue lispro in variable combination with NPH insulin at mealtime Diabetes Care 1999 22 468 477
11. Boland EA Grey M Oesterle A Fredrickson L Tamborlane WV Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes Diabetes Care 1999 22 1779 1784
12. Bode BW Steed RD Davidson PC Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes Diabetes Care 1996 19 324 327
13. Linkeschova R Raoul M Bott U Berger M Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years Diabet Med 2002 19 746 751
14. Weintrob N Benzaquen H Galatzer A Shalitin S Lazar L Fayman G et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial Pediatrics 2003 112 559 564
15. Raskin P Bode BW Marks JB Hirsch IB Weinstein RL McGill JB et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in Type 2 diabetes Diabetes Care 2003 26 2598 2603
16. National Institute for Clinical Excellence. Final appraisal determination. Long-acting insulin analogues for the treatment of diabetes - insulin glargine October 2002 Available from:
17. The Diabetes Control and Complications Trial Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT) Diabetes Care 1988 11 725 732
18. Jenkinson C Layte R Development and testing of the UK SF-12 (short form health survey) J Health Serv Res Policy 1997 2 14 18
19. Westlake WJ Use of confidence intervals in analysis of comparative bioavailability trials J Pharm Sci 1972 61 1340 1341
20. Westlake WJ Response to T. B. L. Kirkwood - bioequivalence testing: a need to rethink Biometrics 1981 37 591 593
21. Porcellati F Rossetti P Pampanelli S Fanelli CG Torlone E Scionti L et al. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin Diabet Med 2004 21 1213 1220
22. DeVries JH Snoek FJ Kostense PJ Masurel N Heine RJ A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control Diabetes Care 2002 25 2074 2080
23. Doyle EA Weinzimer SA Steffen AT Ahern JA Vincent M Tamborlane WV A randomised, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine Diabetes Care 2004 27 1554 1558
24. Bolli GB Capani F Home PD Kerr D Thomas R Torlone E et al. Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro to continuous subcutaneous insulin infusion: a randomised, open, parallel study Diabetes 2004 53 A107 A108
25. King AB Armstrong D A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine Diabetes Care 2003 26 1322
26. Bruttomesso D Pianta A Crazzolara D Scaldaferri E Lora L Guarneri G et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life Diabet Med 2002 19 628 634
27. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial Diabetes 1995 44 968 983
28. 1c Insuman Infusat (R) and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study Diabetes Metab 2000 26 192 196
29. Schiffers T Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump Psychother Psychosom Med Psychol 1997 47 249 254
30. Müller UA Femerling M Reinauer KM Risse A Voss M Jorgens V et al. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association) Diabetes Care 1999 22 29 34